DOI: https://doi.org/10.22141/2224-0586.7.70.2015.78716

Hypertension: a Disease or a Risk Factor?

J.E. Vasquez Abanto, A.E. Vasquez Abanto, S.B. Arellano Vasquez

Abstract


In studies, published by some researchers (De la Sierra A. and González-Segura D.) in 2011, and by others (Martell-Claros N., Galgo-Nafria A.) in 2012, there were stu-died the risk factors for cardiovascular diseases that emphasizes their crucial role in the occurrence of cardiovascular events. In addition to dyslipidemia, hypertension is an important factor for cardiovascular diseases and worsening of their prognosis.
At the level of primary health care, particularly in emergency medicine, there are high rates of calls due to circulatory di-seases, among which calls due to hypertension are dominated. At that, hypertension as a concomitant diagnosis accompanies almost every case of the call for circulatory diseases.
Quantitative analysis of calls serviced by emergency team, according to disease entities, leads to the conclusion that most serviced calls are the calls due to circulatory diseases, essential hypertension with crises, respiratory, digestive and nervous system diseases. The percentage of circulatory diseases and essential hypertension with crises among all served calls (for 3-year period) is 40.84 and 25.74 %, respectively.


Keywords


hypertension; cardiovascular diseases; risk; cardiology; pressure

References


Васкес Абанто Х.Э., Васкес Абанто А.Э. Болезни системы кровообращения в медицине неотложных состояний // Материалы III Всероссийской конференции «Противоречия современной кардиологии: спорные и нерешенные вопросы» (7–8 ноября 2014 года). — Самара, 2014. — 170 с.

Васкес Абанто Х.Э., Васкес Абанто А.Э. Из практики медицины неотложных состояний // Новости медицины и фармации. — 2014. — 15 (509). — С. 22-25.

Васкес А.Х.Э., Васкес А.А.Э., Арельяно В.С.Б. Кардиология в практике врача экстренной медицины // Тезисы юбилейной Всероссийской научно-практической конференции (55-я ежегодная сессия РКНПК) «70 лет борьбы за жизнь» в Москве 1–2 июня 2015 г.

Рабочая группа по лечению артериальной гипертонии Европейского общества гипертонии (European Society of Hypertension, ESH) и Европейского общества кардиологов (European Society of Cardiology, ESC). Рекомендации по лечению артериальной гипертонии. ESH/ESC 2013 // Российский кардио-логический журнал. — 2014. — 1 (105). — 7-94.

De la Sierra A., González-Segura D. Risk factors in hypertensive patients without previous cardiovascular events [Article in Spanish] // Med. Clin. (Barc.). — 2011 May 14. — 136 (13). — 559-64. doi: 10.1016/j.medcli.2010.11.025. Epub 2011 Mar 11. [Доступно в: http. — //www.ncbi.nlm.nih.gov/pubmed/?term = manejo+de+la+hipertension+arterial].

Dulin B.R., Haas S.J., Abraham W.T., Krum H. Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of > 12,000 patients in large-scale clinical trials // Am. J. Cardiol. — 2005. — 95 (7). — 896-8. [Доступно в: PubMed, http. — //www.ncbi.nlm.nih.gov/pubmed/15781028].

Guo F., He D., Zhang W., Walton R.G. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010 // J. Am. Coll Cardiol. — 2012. — 60 (7). — 599-606. [PubMed, http. — //www.ncbi.nlm.nih.gov/pubmed/22796254].

Heidenreich P.A., Trogdon J.G., Khavjou O.A. et al. Forecas-ting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association // Circulation. — 2011. — 123 (8). — 933-44. [PubMed, http. — //www.ncbi.nlm.nih.gov/pubmed/21262990].

James P.A., Oparil S., Carter B.L. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) // JAMA. — 2014. — 311. — 507-520. doi. — 10.1001/jama.2013.284427. [Доступно в: http. — //jama.jamanetwork.com/article.aspx?articleid = 1791497].

Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: Analysis of worldwide data // Lancet. — 2005. — 365. — 217-23 [Доступно в: PubMed, http. — //www.ncbi.nlm.nih.gov/pubmed/15652604].

Marcano Pasquier R. Las nuevas pautas del JNC 8 para el manejo de la hipertensión // www.medicinapreventiva.info. October 2014.

Marin Marcos J., Fábregues Guillermo. Registro Nacional de Hipertensión Arterial. Conocimiento,tratamiento y control de la hipertensión arterial. Estudio RENATA (National Registry of Hypertension. Awareness, Treatment and Control of Hypertension. The RENATA Study) // Rev. argent. cardiol. — 2012. — Vol. 80, № 2. Ciudad Autónoma de Buenos Aires, abr. [Доступно в: http. — //www.scielo.org.ar/scielo.php?script = sci_arttext&pid = S1850-37482012000200005].

Martell-Claros N. Cardiovascular risk profile of young hypertensive patients: the OPENJOVEN study // Eur. J. Prev. Cardiol. — 2012 Jun. — 19 (3). — 534-40. DOI: 10.1177/1741826711406202. Epub 2011 Apr 7. [Доступно в: PubMed, http. — //www.ncbi.nlm.nih.gov/pubmed/21474438].

OMS/WHO. Informacion general sobre la hipertensión en el mundo. Dia Mundial de la Salud 2013. WHO/DCO/WHD/2013.2 [Доступно в: http. — //www.who.int/cardiovascular_diseases/publications/global_brief_hypertension/es/].

OMS/WHO. Preguntas y respuestas sobre la hipertensión. Marzo de 2013 [Доступно в: http. — //www.who.int/features/qa/82/es/].

Petrák O., Zelinka T., Štrauch B., Rosa J., Šomlóová Z., Indra T., Turková H., Holaj R., Widimský J. Jr. Combination antihypertensive therapy in clinical practice. The analysis of 1254 consecutive patients with uncontrolled hypertension // J. Hum. Hypertens. (Journal of Human Hypertension). — 2015 Apr 2. doi: 10.1038/jhh.2015.24 [Доступно в: PubMed, http. — //www.ncbi.nlm.nih.gov/pubmed/25833703].

Reule Scott, Drawz Paul E. Heart Rate and Blood Pressure: Any Possible Implications for Management of Hypertension? // Curr Hypertens Rep. — 2012 Dec. — 14 (6). — 478-484. [Доступно в: PubMed, http. — //www.ncbi.nlm.nih.gov/pmc/articles/PMC3491126/].

Sarafidis P.A., Bakris G.L. Resistant hypertension: an overview of evaluation and treatment // J. Am. Coll. Cardiol. — 2008. — 52. — 1749-57 [Доступно в: PubMed, http. — //www.ncbi.nlm.nih.gov/pubmed/?term = Sarafidis+P.A. %2C+Bakris+G.L.+Resistant+hypertension %3A+an+overview+of+evaluation+and+treatment].

Takashi Kanaia, Henry Krum. Un tratamiento nuevo para una enfermedad antigua: tratamiento de la hipertensión arterial resistente mediante denervación simpática renal percutánea // Rev. Esp. Cardiol. — 2013 [Доступно в: http. — //www.revespcardiol.org/es/un-tratamiento-nuevo-una-enfermedad/articulo/90219244/#t0005].




Copyright (c) 2016 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта